Recent advances in radiotherapy of breast cancer.


Journal

Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111

Informations de publication

Date de publication:
30 Mar 2020
Historique:
received: 28 01 2020
accepted: 18 02 2020
entrez: 2 4 2020
pubmed: 2 4 2020
medline: 3 2 2021
Statut: epublish

Résumé

Radiation therapy is an integral part of the multidisciplinary management of breast cancer. Regional lymph node irradiation in younger trials seems to provide superior target coverage as well as a reduction in long-term toxicity resulting in a small benefit in the overall survival rate. For partial breast irradiation there are now two large trials available which support the role of partial breast irradiation in low risk breast cancer patients. Multiple randomized trials have established that a sequentially applied dose to the tumor bed improves local control with the cost of worse cosmetic results.

Identifiants

pubmed: 32228654
doi: 10.1186/s13014-020-01501-x
pii: 10.1186/s13014-020-01501-x
pmc: PMC7106718
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

71

Références

JAMA. 2017 Sep 12;318(10):918-926
pubmed: 28898379
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):263-269
pubmed: 29066123
Radiother Oncol. 2013 Aug;108(2):197-202
pubmed: 23742961
Eur J Surg Oncol. 2017 Apr;43(4):672-679
pubmed: 28139362
Lancet. 2019 Dec 14;394(10215):2165-2172
pubmed: 31813635
Strahlenther Onkol. 2019 Jan;195(1):13-20
pubmed: 30143814
J Clin Oncol. 1997 Mar;15(3):963-8
pubmed: 9060534
Radiother Oncol. 2018 Jan;126(1):155-162
pubmed: 29153463
J Med Radiat Sci. 2015 Mar;62(1):74-81
pubmed: 26229670
Lancet Oncol. 2013 Dec;14(13):1269-77
pubmed: 24225155
Strahlenther Onkol. 2019 Jul;195(7):615-628
pubmed: 31101954
Strahlenther Onkol. 2018 Mar;194(3):196-205
pubmed: 28916844
Breast Care (Basel). 2018 Aug;13(4):285-291
pubmed: 30319331
Radiat Oncol. 2019 Aug 28;14(1):153
pubmed: 31462267
Strahlenther Onkol. 2002 Nov;178(11):615-23
pubmed: 12426672
Cochrane Database Syst Rev. 2016 Jul 18;7:CD003860
pubmed: 27425588
Radiother Oncol. 2019 Feb;131:202-207
pubmed: 30097250
Med Oncol. 2019 Apr 25;36(6):48
pubmed: 31028487
Crit Rev Oncol Hematol. 2019 Sep;141:102-111
pubmed: 31272045
J Clin Oncol. 2014 Nov 10;32(32):3600-6
pubmed: 25135994
Radiother Oncol. 2013 Aug;108(2):203-8
pubmed: 24044803
Radiat Oncol. 2016 Oct 26;11(1):143
pubmed: 27784326
Radiother Oncol. 2019 Dec;141:327-328
pubmed: 31451283
J Med Radiat Sci. 2015 Mar;62(1):66-73
pubmed: 26229669
Lancet. 2019 Dec 14;394(10215):2155-2164
pubmed: 31813636
Breast Care (Basel). 2019 Jun;14(3):152-158
pubmed: 31316313
Radiat Oncol. 2019 Jul 2;14(1):115
pubmed: 31266510
Strahlenther Onkol. 2014 Jul;190(7):646-53
pubmed: 24737540
J Clin Oncol. 2017 May 20;35(15):1641-1649
pubmed: 28319436
Radiat Oncol. 2019 Jun 11;14(1):102
pubmed: 31186015
J Radiat Res. 2019 Oct 23;60(5):694-704
pubmed: 31365118
Radiat Oncol. 2019 Oct 14;14(1):175
pubmed: 31610801
Cochrane Database Syst Rev. 2016 Jul 18;7:CD007077
pubmed: 27425375
Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e51-e56
pubmed: 27890346
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):503-510
pubmed: 31654782
Breast Care (Basel). 2015 Apr;10(2):131-5
pubmed: 26195942
J Natl Cancer Inst. 2005 Jan 19;97(2):116-26
pubmed: 15657341
N Engl J Med. 2010 Feb 11;362(6):513-20
pubmed: 20147717
N Engl J Med. 1997 Oct 2;337(14):956-62
pubmed: 9309100
Radiother Oncol. 2016 Jul;120(1):107-13
pubmed: 27247055
Eur J Cancer. 2015 Mar;51(4):451-63
pubmed: 25605582
Radiat Oncol. 2018 Jul 27;13(1):135
pubmed: 30053864
Radiother Oncol. 2019 Mar;132:148-154
pubmed: 30414755
Lancet Oncol. 2019 Mar;20(3):352-360
pubmed: 30711522
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
Lancet. 2014 Feb 15;383(9917):603-13
pubmed: 24224997
Strahlenther Onkol. 2019 Jan;195(1):1-12
pubmed: 30310926
Math Biosci Eng. 2019 Sep 26;17(1):92-104
pubmed: 31731341
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):19-25
pubmed: 20471183
Lancet. 2017 Sep 9;390(10099):1048-1060
pubmed: 28779963
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):259-265
pubmed: 27478165
Radiother Oncol. 2013 Aug;108(2):248-53
pubmed: 24044804
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Lancet Oncol. 2015 Jan;16(1):47-56
pubmed: 25500422

Auteurs

Jan Haussmann (J)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Stefanie Corradini (S)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Carolin Nestle-Kraemling (C)

Department of Gynecologic and Obstetrics, Evanglisches Krankenhaus Dusseldorf, Dusseldorf, Germany.

Edwin Bölke (E)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany. boelke@med.uni-duesseldorf.de.

Freddy Joel Djiepmo Njanang (FJD)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Bálint Tamaskovics (B)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Klaus Orth (K)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Eugen Ruckhaeberle (E)

Department of Gynecology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.

Tanja Fehm (T)

Department of Gynecology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.

Svjetlana Mohrmann (S)

Department of Gynecology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.

Ioannis Simiantonakis (I)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Wilfried Budach (W)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Christiane Matuschek (C)

Medical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH